A new study reports researchers have identified a drug that targets the first steps in a toxic chain reaction that leads to Alzheimer's disease.
According to a new study, researchers believe they have discovered a potential new cause of Alzheimer's disease.
Researchers report a lifelong accumulation of amyloid plaques in the brain could contribute to Alzheimer's disease.
Study reveals how the SNX27 protein regulates the generation of beta amyloid.
Researchers report the brain is able to compensate for a buildup of beta amyloid, a protein associated with Alzheimer's disease.
Limiting the p25 protein appears to reverse AD symptoms in mice, a new study reports.
Pericytes could provide novel targets for the treatment and diagnosis of Alzheimer's disease, a new study reports.
A new study reports even low levels of APOE4 can increase beta-amyloid plaques in the brain and neuronal damage in mouse models of Alzheimer's disease. However, introducing APOE2 can reduce amyloid deposits and other associated damage.
Researchers use a novel genomic approach to better understand genetic mutations associated with familial Alzheimer's disease.
According to a new study, middle aged people with high pulse pressure are more likely to have biomarkers for Alzheimer's disease in their spinal fluid than those with lower pulse pressure.
Researchers have discovered six proteins in spinal fluid which could be used as biomarkers for Alzheimer's disease.
Shorter periods of sleep and poorer quality of sleep are associated with greater buildup of beta anyloid, a new study reports.
